North America Synthetic Biology Market Size & Outlook
North America synthetic biology market, 2018-2030 (US$M)
Related Markets
North America synthetic biology market highlights
- The North America synthetic biology market generated a revenue of USD 5,851.9 million in 2023.
- The market is expected to grow at a CAGR of 22.9% from 2024 to 2030.
- In terms of segment, pcr technology was the largest revenue generating technology in 2023.
- NGS Technology is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 5,851.9 million |
| Market revenue in 2030 | USD 24,848.8 million |
| Growth rate | 22.9% (CAGR from 2023 to 2030) |
| Largest segment | Pcr technology |
| Fastest growing segment | NGS Technology |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies |
| Key market players worldwide | Basf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 41.4% of the global synthetic biology market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 14,445.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Synthetic Biology Market Scope
Synthetic Biology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America synthetic biology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to synthetic biology market will help companies and investors design strategic landscapes.
Pcr technology was the largest segment with a revenue share of 27.63% in 2023. Horizon Databook has segmented the North America synthetic biology market based on ngs technology, pcr technology, genome editing technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
North America holds the largest market share of synthetic biology market due to increased investments in private companies, favorable regulations, and government assistance. The U.S. majorly focuses on research being done in the area of drug discovery, proteomics, and genomics structure prediction, thereby propelling growth of synthetic biology market.
Several research institutes receiving funding from government organizations, such as National Institutes of Health (NIH), and private organizations, such as Bill & Melinda Gates Foundation, for DNA sequencing &biological components and developing various bioinformatics, which can be used for several healthcare applications.
Furthermore, increasing funding in synthetic biology companies is expected to drive the market growth in North America. The following table mentions some North American synthetic biology companies that received significant funding in the first half of 2020.
Reasons to subscribe to North America synthetic biology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America synthetic biology market databook
-
Our clientele includes a mix of synthetic biology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America synthetic biology market , including forecasts for subscribers. This continent databook contains high-level insights into North America synthetic biology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America synthetic biology market size, by country, 2018-2030 (US$M)
North America Synthetic Biology Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
